Clinical trial
Vasodilator Induced Stress In CONcordance With Adenosine (VISION-302)
NCT00944294 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vasodilator Induced Stress In CONcordance With Adenosine (VISION-302)
- Lead sponsor
- Pfizer
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 29, 2004
- Completion date
- April 30, 2006
- Enrollment
- 419 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.